Business Information
The group's principal activity is to develop therapeutic products for treatment of cancer and prevention of infectious diseases. The product categories include vaccines for the treatment of cancer and the treatment and prevention of infectious diseases and complex proteins for therapeutic product applications. It applies proprietary proteomics, functional genomics, and biomanufacturing technologies to develop and manufacture drugs and vaccines for effective treatment of diseases. The corporate office and genomics research facility is located in vacaville, California. The group's biomanufacturing plant is located in owensboro, Kentucky, and the proteomics research facility is located in germantown, Maryland.
|
|
Name |
Title
|
Email
|
| Robert Erwin | Chmn. | N/A | | Kevin Ryan | CEO, Pres. | N/A | | Laurence Grill | Sr. VP - Research, Chief Scientific Officer | N/A | | Ronald Artale | Sr. VP, CFO, COO, Sec. | N/A | | Daniel Tuse | VP - Business Development | N/A |
|
|
Year |
Sales |
Net Income |
| 2004 | 1,767 | (17,425) | | 2003 | 3,570 | (25,293) | | 2002 | 2,622 | (33,184)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
